Angiotensin-I-converting enzyme inhibitors may be an alternative anti-angiogenic strategy in the treatment of liver fibrosis and hepatocellular carcinoma. Possible role of vascular endothelial growth factor (Q35099632)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Angiotensin-I-converting enzyme inhibitors may be an alternative anti-angiogenic strategy in the treatment of liver fibrosis and hepatocellular carcinoma. Possible role of vascular endothelial growth factor |
scientific article |
Statements
1 reference
Angiotensin-I-converting enzyme inhibitors may be an alternative anti-angiogenic strategy in the treatment of liver fibrosis and hepatocellular carcinoma. Possible role of vascular endothelial growth factor (English)
1 reference
Hitoshi Yoshiji
1 reference
Shigeki Kuriyama
1 reference
Hiroshi Fukui
1 reference
1 November 2002
1 reference
1 reference
23
1 reference
6
1 reference
348-356
1 reference
Identifiers
1 reference
1 reference